Displaying 1 - 8 of 8
PurposeThe Society for Integrative Oncology (SIO) produced an evidence-based guideline on use of integrative therapies during and after breast cancer treatment that was determined to be relevant to the American Society of Clinical Oncology (ASCO) membership. ASCO considered the guideline for endorsement.MethodsThe SIO guideline addressed the use of integrative therapies for the management of symptoms and adverse effects, such as anxiety and stress, mood disorders, fatigue, quality of life, chemotherapy-induced nausea and vomiting, lymphedema, chemotherapy-induced peripheral neuropathy, pain, and sleep disturbance. Interventions of interest included mind and body practices, natural products, and lifestyle modifications. SIO systematic reviews focused on randomized controlled trials that were published from 1990 through 2015. The SIO guideline was reviewed by ASCO content experts for clinical accuracy and by ASCO methodologists for developmental rigor. On favorable review, an ASCO Expert Panel was convened to review the guideline contents and recommendations.ResultsThe ASCO Expert Panel determined that the recommendations in the SIO guidelinepublished in 2017are clear, thorough, and based on the most relevant scientific evidence. ASCO endorsed the guideline with a few added discussion points.RecommendationsKey recommendations include the following: Music therapy, meditation, stress management, and yoga are recommended for anxiety/stress reduction. Meditation, relaxation, yoga, massage, and music therapy are recommended for depression/mood disorders. Meditation and yoga are recommended to improve quality of life. Acupressure and acupuncture are recommended for reducing chemotherapy-induced nausea and vomiting. Acetyl-l-carnitine is not recommended to prevent chemotherapy-induced peripheral neuropathy because of a possibility of harm. No strong evidence supports the use of ingested dietary supplements to manage breast cancer treatment-related adverse effects. Additional information is available at: www.asco.org/supportive-care-guidelines.
Yoga is regarded in the West mainly as a physical activity. However, increasing evidence supports yoga's efficacy as an adjunct treatment for complex mental health issues. This study explored the suitability of an integrated mindful yoga programme in a mental health rehabilitation centre. Ten psychiatric inpatients participated in twice-weekly 30 minute sessions over seven weeks. Semi-structured interviews and weekly journal entries were utilized to explore reasons for attending the yoga, challenges, barriers, and the programme's impact on achieving personal objectives. Themes included increased relaxation, reduced stress, improved energy, greater ability to focus, and further motivation to engage in life. These findings support the potential benefits of yoga programmes for people experiencing psychosis.
The aim of this study was to explore the feasibility of implementing a new 8-week mindfulness-based programme, ‘Mindfulness-Based Coping with University Life’ (MBCUL), specifically tailored to the needs and demand of students and to explore its impact in a pilot evaluation. Participants were drawn from the University of Northampton (MBCUL N = 10; control N = 6). A non-randomized wait-list-controlled design was employed. Measures examined anxiety and depression, perceived stress, mindfulness and personally relevant change before and immediately after the programme. The diurnal profile of salivary cortisol and alpha-amylase level was collected for two consecutive days. No significant intergroup differences were observed on any of the measures at either time point. However, significant change was observed for the MBCUL group in terms of perceived stress (d = 1.06; z = −2.25, p = 0.03), anxiety (d = 1.04; z = −2.14, p = 0.03), depression (d = 0.52; z = −0.69, p = 0.5) and personally relevant change (d = 2.63; z = −2.68, p = 0.01), along with an increase in mindfulness (d = 1.06; z = −1.89, p = 0.06). In contrast, no significant change was found in the daily profiles of cortisol and alpha-amylase. The data from this pilot tentatively suggest that MBCUL appears to be a promising programme that warrants further evaluation using a randomized study with a larger sample size. Copyright © 2011 John Wiley & Sons, Ltd.